Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study.
Saved in:
| Title: | Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study. |
|---|---|
| Authors: | Verbeek MWC; Laboratory for Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Rodríguez BS; Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Sedek L; Department of Microbiology and Immunology, Medical University of Silesia in Katowice, Zabrze, Poland.; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia in Katowice, Katowice, Poland., Laqua A; Department of Hematology, University of Schleswig-Holstein, Kiel, Germany., Buracchi C; Centro Tettamanti, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Buysse M; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium., Reiterová M; CLIP-Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Oliveira E; Pediatrics Institute IPPMG, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Morf D; Institute for Laboratory Medicine, Aarau, Switzerland., Oude Alink SR; Laboratory for Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Barrena S; Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Kohlscheen S; Department of Hematology, University of Schleswig-Holstein, Kiel, Germany., Nierkens S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hofmans M; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium., Fernandez P; Institute for Laboratory Medicine, Aarau, Switzerland., de Costa ES; Pediatrics Institute IPPMG, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Mejstrikova E; CLIP-Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Szczepanski T; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia in Katowice, Katowice, Poland., Slota L; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia in Katowice, Katowice, Poland., Brüggemann M; Department of Hematology, University of Schleswig-Holstein, Kiel, Germany., Gaipa G; Centro Tettamanti, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Grigore G; Cytognos SL, Salamanca, Spain., van Dongen JJM; Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Department of Immunology, Leiden University Medical Center (LUMC), The Netherlands., Orfao A; Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., van der Velden VHJ; Laboratory for Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. |
| Source: | Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2024 Jul; Vol. 106 (4), pp. 252-263. Date of Electronic Publication: 2023 Sep 22. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 101235690 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4957 (Electronic) Linking ISSN: 15524949 NLM ISO Abbreviation: Cytometry B Clin Cytom Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37740440 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Verbeek+MWC%22">Verbeek MWC</searchLink>; Laboratory for Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Rodríguez+BS%22">Rodríguez BS</searchLink>; Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Sedek+L%22">Sedek L</searchLink>; Department of Microbiology and Immunology, Medical University of Silesia in Katowice, Zabrze, Poland.; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia in Katowice, Katowice, Poland.<br /><searchLink fieldCode="AU" term="%22Laqua+A%22">Laqua A</searchLink>; Department of Hematology, University of Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Buracchi+C%22">Buracchi C</searchLink>; Centro Tettamanti, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.<br /><searchLink fieldCode="AU" term="%22Buysse+M%22">Buysse M</searchLink>; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Reiterová+M%22">Reiterová M</searchLink>; CLIP-Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Oliveira+E%22">Oliveira E</searchLink>; Pediatrics Institute IPPMG, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.<br /><searchLink fieldCode="AU" term="%22Morf+D%22">Morf D</searchLink>; Institute for Laboratory Medicine, Aarau, Switzerland.<br /><searchLink fieldCode="AU" term="%22Oude+Alink+SR%22">Oude Alink SR</searchLink>; Laboratory for Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Barrena+S%22">Barrena S</searchLink>; Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Kohlscheen+S%22">Kohlscheen S</searchLink>; Department of Hematology, University of Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Nierkens+S%22">Nierkens S</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hofmans+M%22">Hofmans M</searchLink>; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Fernandez+P%22">Fernandez P</searchLink>; Institute for Laboratory Medicine, Aarau, Switzerland.<br /><searchLink fieldCode="AU" term="%22de+Costa+ES%22">de Costa ES</searchLink>; Pediatrics Institute IPPMG, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.<br /><searchLink fieldCode="AU" term="%22Mejstrikova+E%22">Mejstrikova E</searchLink>; CLIP-Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Szczepanski+T%22">Szczepanski T</searchLink>; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia in Katowice, Katowice, Poland.<br /><searchLink fieldCode="AU" term="%22Slota+L%22">Slota L</searchLink>; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia in Katowice, Katowice, Poland.<br /><searchLink fieldCode="AU" term="%22Brüggemann+M%22">Brüggemann M</searchLink>; Department of Hematology, University of Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Gaipa+G%22">Gaipa G</searchLink>; Centro Tettamanti, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.<br /><searchLink fieldCode="AU" term="%22Grigore+G%22">Grigore G</searchLink>; Cytognos SL, Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22van+Dongen+JJM%22">van Dongen JJM</searchLink>; Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Department of Immunology, Leiden University Medical Center (LUMC), The Netherlands.<br /><searchLink fieldCode="AU" term="%22Orfao+A%22">Orfao A</searchLink>; Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22van+der+Velden+VHJ%22">van der Velden VHJ</searchLink>; Laboratory for Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101235690%22">Cytometry. Part B, Clinical cytometry</searchLink> [Cytometry B Clin Cytom] 2024 Jul; Vol. 106 (4), pp. 252-263. <i>Date of Electronic Publication: </i>2023 Sep 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101235690 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1552-4957 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215524949%22">15524949 </searchLink><i>NLM ISO Abbreviation: </i>Cytometry B Clin Cytom <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37740440 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cyto.b.22143 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 252 Titles: – TitleFull: Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Verbeek MWC – PersonEntity: Name: NameFull: Rodríguez BS – PersonEntity: Name: NameFull: Sedek L – PersonEntity: Name: NameFull: Laqua A – PersonEntity: Name: NameFull: Buracchi C – PersonEntity: Name: NameFull: Buysse M – PersonEntity: Name: NameFull: Reiterová M – PersonEntity: Name: NameFull: Oliveira E – PersonEntity: Name: NameFull: Morf D – PersonEntity: Name: NameFull: Oude Alink SR – PersonEntity: Name: NameFull: Barrena S – PersonEntity: Name: NameFull: Kohlscheen S – PersonEntity: Name: NameFull: Nierkens S – PersonEntity: Name: NameFull: Hofmans M – PersonEntity: Name: NameFull: Fernandez P – PersonEntity: Name: NameFull: de Costa ES – PersonEntity: Name: NameFull: Mejstrikova E – PersonEntity: Name: NameFull: Szczepanski T – PersonEntity: Name: NameFull: Slota L – PersonEntity: Name: NameFull: Brüggemann M – PersonEntity: Name: NameFull: Gaipa G – PersonEntity: Name: NameFull: Grigore G – PersonEntity: Name: NameFull: van Dongen JJM – PersonEntity: Name: NameFull: Orfao A – PersonEntity: Name: NameFull: van der Velden VHJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2024 Jul Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1552-4957 Numbering: – Type: volume Value: 106 – Type: issue Value: 4 Titles: – TitleFull: Cytometry. Part B, Clinical cytometry Type: main |
| ResultId | 1 |
